Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update

Progress in Cardiovascular Diseases

Volumn 61, Issue 2, 2018, Pages 103-113

  Piché, Marie Eve ^a,b   Poirier, Paul ^a,b   Lemieux, Isabelle ^a   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Bariatric surgery; Body fat distribution; Cardiovascular disease; Heart failure; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL SUBCUTANEOUS FAT; ANGINA PECTORIS; ATRIAL FIBRILLATION; BILIOPANCREATIC BYPASS; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; EPICARDIAL FAT; FOLLOW UP; GASTRIC BANDING; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; ROUX-EN-Y GASTRIC BYPASS; SELF REPORT; SLEEVE GASTRECTOMY; SUBCUTANEOUS FAT; SUDDEN CARDIAC DEATH; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADIPOSE TISSUE; BARIATRIC SURGERY; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; RISK REDUCTION; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADIPOSITY; BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; HUMANS; OBESITY; PHENOTYPE; PREVALENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 85049481100     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2018.06.004     Document Type: Review

References (152)

1. Health, United States, With special feature on racial and ethnic health disparities. Hyattsville (MD)2016. 2015.
2. Collaborators GBDO, Afshin, A., Forouzanfar, M.H., et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377 (2017), 13–27.
3. Ng, M., Fleming, T., Robinson, M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet 384 (2014), 766–781.
4. Hales, C.M., Fryar, C.D., Carroll, M.D., Freedman, D.S., Ogden, C.L., Trends in obesity and severe obesity prevalence in us youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA 319 (2018), 1723–1725.
5. Flegal, K.M., Kit, B.K., Orpana, H., Graubard, B.I., Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309 (2013), 71–82.
6. Composition corporelle des adultes canadiens, 2009 à 2011. Stat Can, 2013.
7. Keys, A., Fidanza, F., Karvonen, M.J., Kimura, N., Taylor, H.L., Indices of relative weight and obesity. J Chronic Dis 25 (1972), 329–343.
8. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 894(i-xii), 2000, 1–253.
9. Poirier, P., Giles, T.D., Bray, G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26 (2006), 968–976.
10. Lavie, C.J., Arena, R., Alpert, M.A., Milani, R.V., Ventura, H.O., Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol 15 (2018), 45–56.
11. Poirier, P., Alpert, M.A., Fleisher, L.A., et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation 120 (2009), 86–95.
12. Poirier, P., Giles, T.D., Bray, G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation 113 (2006), 898–918.
13. Flegal, K.M., Carroll, M.D., Ogden, C.L., Johnson, C.L., Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288 (2002), 1723–1727.
14. Sturm, R., Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 163 (2003), 2146–2148.
15. Sturm, R., Hattori, A., Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) 37 (2013), 889–891.
16. Wormser, D., Kaptoge, S., Di Angelantonio, E., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377 (2011), 1085–1095.
17. Bastien, M., Poirier, P., Lemieux, I., Després, J.P., Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56 (2014), 369–381.
18. Rabkin, S.W., Mathewson, F.A.L., Hsu, P.H., Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: the Manitoba study. Am J Cardiol 39 (1977), 452–458.
19. Hubert, H.B., Feinleib, M., McNamara, P.M., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67 (1983), 968–977.
20. Plourde, B., Sarrazin, J.F., Nault, I., Poirier, P., Sudden cardiac death and obesity. Expert Rev Cardiovasc Ther 12 (2014), 1099–1110.
21. Poirier, P., Cornier, M.A., Mazzone, T., et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation 123 (2011), 1683–1701.
22. Abraham, T.M., Pedley, A., Massaro, J.M., Hoffmann, U., Fox, C.S., Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation 132 (2015), 1639–1647.
23. Liu, J., Fox, C.S., Hickson, D.A., et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab 95 (2010), 5419–5426.
24. Neeland, I.J., Poirier, P., Despres, J.P., Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation 137 (2018), 1391–1406.
25. Després, J.P., Body fat distribution and risk of cardiovascular disease: an update. Circulation 126 (2012), 1301–1313.
26. Karpe, F., Pinnick, K.E., Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes. Nat Rev Endocrinol 11 (2015), 90–100.
27. Tchernof, A., Després, J.P., Pathophysiology of human visceral obesity: an update. Physiol Rev 93 (2013), 359–404.
28. Dobson, R., Burgess, M.I., Sprung, V.S., et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond) 40 (2016), 153–161.
29. Snijder, M.B., Dekker, J.M., Visser, M., et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 77 (2003), 1192–1197.
30. Thomas, E.L., Saeed, N., Hajnal, J.V., et al. Magnetic resonance imaging of total body fat. J Appl Physiol 85 (1998), 1778–1785.
31. Kvist, H., Ströström, L., Tylen, U., Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes 10 (1986), 53–67.
32. Marinou, K., Hodson, L., Vasan, S.K., et al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care 37 (2014), 821–829.
33. Fox, C.S., Massaro, J.M., Hoffmann, U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 116 (2007), 39–48.
34. Preis, S.R., Massaro, J.M., Robins, S.J., et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 18 (2010), 2191–2198.
35. Fujimoto, W.Y., Bergstrom, R.W., Boyko, E.J., et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American community diabetes study. Diabetes Care 22 (1999), 1808–1812.
36. Liu, J., Fox, C.S., Hickson, D., Bidulescu, A., Carr, J.J., Taylor, H.A., Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson heart study. Arterioscler Thromb Vasc Biol 31 (2011), 2715–2722.
37. Rosito, G.A., Massaro, J.M., Hoffmann, U., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study. Circulation 117 (2008), 605–613.
38. Després, J.P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
39. Virtue, S., Vidal-Puig, A., Adipose tissue expandability, lipotoxicity and the metabolic syndrome–an allostatic perspective. Biochim Biophys Acta 1801 (2010), 338–349.
40. Jensen, M.D., Johnson, C.M., Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism 45 (1996), 662–666.
41. Britton, K.A., Fox, C.S., Ectopic fat depots and cardiovascular disease. Circulation 124 (2011), e837–e841.
42. Virtue, S., Vidal-Puig, A., It's not how fat you are, it's what you do with it that counts. PLoS Biol, 6, 2008, e237.
43. Iacobellis, G., Bianco, A.C., Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22 (2011), 450–457.
44. Iozzo, P., Myocardial, perivascular, and epicardial fat. Diabetes Care 34:Suppl 2 (2011), S371–S379.
45. Iacobellis, G., Corradi, D., Sharma, A.M., Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2 (2005), 536–543.
46. Szczepaniak, L.S., Dobbins, R.L., Metzger, G.J., et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49 (2003), 417–423.
47. Shirani, J., Berezowski, K., Roberts, W.C., Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 76 (1995), 414–418.
48. Liu, J., Fox, C.S., Hickson, D., et al. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study. Diabetes Care 33 (2010), 1635–1639.
49. Shimabukuro, M., Hirata, Y., Tabata, M., et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 33 (2013), 1077–1084.
50. Levelt, E., Rodgers, C.T., Clarke, W.T., et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J 37 (2016), 3461–3469.
51. McGavock, J.M., Victor, R.G., Unger, R.H., Szczepaniak, L.S., American College of P, the American physiological S. Adiposity of the heart, revisited. Ann Intern Med 144 (2006), 517–524.
52. Nissen, S.E., Wolski, K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007), 2457–2471.
53. Iacobellis, G., Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11 (2015), 363–371.
54. Iacobellis, G., Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring) 17:625 (2009), 626–627 author reply.
55. Baker, A.R., Silva, N.F., Quinn, D.W., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol, 5, 2006, 1.
56. Marchington, J.M., Pond, C.M., Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes (Lond) 14 (1990), 1013–1022.
57. Goldberg, I.J., Trent, C.M., Schulze, P.C., Lipid metabolism and toxicity in the heart. Cell Metab 15 (2012), 805–812.
58. Unger, R.H., Lipotoxic diseases. Annu Rev Med 53 (2002), 319–336.
59. D'Souza, K., Nzirorera, C., Kienesberger, P.C., Lipid metabolism and signaling in cardiac lipotoxicity. Biochim Biophys Acta 1861 (2016), 1513–1524.
60. Fukushima, A., Lopaschuk, G.D., Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. Biochim Biophys Acta 1861 (2016), 1525–1534.
61. Rayner, J.J., Banerjee, R., Holloway, C.J., et al. The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity. Int J Obes (Lond) 42 (2018), 441–447.
62. Lanska, D.J., Lanska, M.J., Hartz, A.J., Rimm, A.A., Factors influencing anatomic location of fat tissue in 52,953 women. Int J Obes (Lond) 9 (1985), 29–38.
63. Wells, J.C., Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab 21 (2007), 415–430.
64. Malis, C., Rasmussen, E.L., Poulsen, P., et al. Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. Obes Res 13 (2005), 2139–2145.
65. Canoy, D., Boekholdt, S.M., Wareham, N., et al. Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into Cancer and nutrition in Norfolk cohort: a population-based prospective study. Circulation 116 (2007), 2933–2943.
66. Yusuf, S., Hawken, S., Ounpuu, S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005), 1640–1649.
67. Snijder, M.B., Zimmet, P.Z., Visser, M., Dekker, J.M., Seidell, J.C., Shaw, J.E., Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab study. Int J Obes Relat Metab Disord 28 (2004), 402–409.
68. Vasan, S.K., Osmond, C., Canoy, D., et al. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes (Lond). 42:4 (2018), 850–857.
69. Manolopoulos, K.N., Karpe, F., Frayn, K.N., Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34 (2010), 949–959.
70. Terry, R.B., Stefanick, M.L., Haskell, W.L., Wood, P.D., Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism 40 (1991), 733–740.
71. Choi, S.I., Chung, D., Lim, J.S., et al. Relationship between regional body fat distribution and diabetes mellitus: 2008 to 2010 Korean National Health and nutrition examination surveys. Diabetes Metab J 41 (2017), 51–59.
72. Wiklund, P., Toss, F., Jansson, J.H., et al. Abdominal and gynoid adipose distribution and incident myocardial infarction in women and men. Int J Obes (Lond) 34 (2010), 1752–1758.
73. Sanchez-Lopez, M., Ortega, F.B., Moya-Martinez, P., et al. Leg fat might be more protective than arm fat in relation to lipid profile. Eur J Nutr 52 (2013), 489–495.
74. Okura, T., Nakata, Y., Yamabuki, K., Tanaka, K., Regional body composition changes exhibit opposing effects on coronary heart disease risk factors. Arterioscler Thromb Vasc Biol 24 (2004), 923–929.
75. Tanko, L.B., Bagger, Y.Z., Alexandersen, P., Larsen, P.J., Christiansen, C., Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107 (2003), 1626–1631.
76. Tanko, L.B., Bagger, Y.Z., Alexandersen, P., Larsen, P.J., Christiansen, C., Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women. Eur Heart J 24 (2003), 1531–1537.
77. Page, A., Dumesnil, J.G., Clavel, M.A., et al. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (aortic stenosis progression observation measuring effects of Rosuvastatin). J Am Coll Cardiol 55 (2010), 1867–1874.
78. Lemieux, I., Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?. Arterioscler Thromb Vasc Biol 24 (2004), 795–797.
79. Frayn, K.N., Adipose tissue as a buffer for daily lipid flux. Diabetologia 45 (2002), 1201–1210.
80. Goodpaster, B.H., Kelley, D.E., Wing, R.R., Meier, A., Thaete, F.L., Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48 (1999), 839–847.
81. Sowemimo, O.A., Yood, S.M., Courtney, J., et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 3 (2007), 73–77 [discussion 77].
82. Cornier, M.A., Després, J.P., Davis, N., et al. Assessing adiposity: a scientific statement from the american heart association. Circulation 124 (2011), 1996–2019.
83. Borrell, L.N., Samuel, L., Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health 104 (2014), 512–519.
84. 2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med, 11, 2014, e1001673.
85. Mokdad, A.H., Ford, E.S., Bowman, B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003), 76–79.
86. Zheng, H., Tumin, D., Qian, Z., Obesity and mortality risk: new findings from body mass index trajectories. Am J Epidemiol 178 (2013), 1591–1599.
87. Ortega, F.B., Sui, X., Lavie, C.J., Blair, S.N., Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of Total body fat be a better predictor of cardiovascular disease mortality?. Mayo Clin Proc 91 (2016), 443–455.
88. Dagenais, G.R., Yi, Q., Mann, J.F., Bosch, J., Pogue, J., Yusuf, S., Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 149 (2005), 54–60.
89. de Koning, L., Merchant, A.T., Pogue, J., Anand, S.S., Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 28 (2007), 850–856.
90. Waist circumference and waist–hip ratio: report of a WHO expert consultation, Geneva, 2008 [ISBN 978 92 4 150149 1].
91. Lemieux, I., Pascot, A., Couillard, C., et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?. Circulation 102 (2000), 179–184.
92. Kenchaiah, S., Evans, J.C., Levy, D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002), 305–313.
93. Aune, D., Sen, A., Norat, T., et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation 133 (2016), 639–649.
94. Alpert, M.A., Terry, B.E., Mulekar, M., et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80 (1997), 736–740.
95. Engeland, A., Bjorge, T., Tverdal, A., Sogaard, A.J., Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 15 (2004), 79–85.
96. Ortega, F.B., Silventoinen, K., Tynelius, P., Rasmussen, F., Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ, 345, 2012, e7279.
97. Baker, J.L., Olsen, L.W., Sorensen, T.I., Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357 (2007), 2329–2337.
98. Falkstedt, D., Hemmingsson, T., Rasmussen, F., Lundberg, I., Body mass index in late adolescence and its association with coronary heart disease and stroke in middle age among Swedish men. Int J Obes (Lond) 31 (2007), 777–783.
99. Gambino, K.K., Zumpano, J., Brennan, D.M., Hoogwerf, B.J., High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease: a PreCIS database study. J Cardiovasc Nurs 25 (2010), 99–105.
100. Cho, E., Manson, J.E., Stampfer, M.J., et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 25 (2002), 1142–1148.
101. Eriksson, J.G., Forsen, T., Tuomilehto, J., Osmond, C., Barker, D.J., Early growth and coronary heart disease in later life: longitudinal study. BMJ 322 (2001), 949–953.
102. Syddall, H.E., Sayer, A.A., Simmonds, S.J., et al. Birth weight, infant weight gain, and cause-specific mortality: the Hertfordshire cohort study. Am J Epidemiol 161 (2005), 1074–1080.
103. Bibbins-Domingo, K., Coxson, P., Pletcher, M.J., Lightwood, J., Goldman, L., Adolescent overweight and future adult coronary heart disease. N Engl J Med 357 (2007), 2371–2379.
104. Alpert, M.A., Lavie, C.J., Agrawal, H., Aggarwal, K.B., Kumar, S.A., Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164 (2014), 345–356.
105. Rider, O.J., Cox, P., Tyler, D., Clarke, K., Neubauer, S., Myocardial substrate metabolism in obesity. Int J Obes (Lond) 37 (2013), 972–979.
106. Rodriguez Flores, M., Aguilar Salinas, C., Piche, M.E., Auclair, A., Poirier, P., Effect of bariatric surgery on heart failure. Expert Rev Cardiovasc Ther 15 (2017), 567–579.
107. Oktay, A.A., Lavie, C.J., Milani, R.V., et al. Current perspectives on left ventricular geometry in systemic hypertension. Prog Cardiovasc Dis 59 (2016), 235–246.
108. Lavie, C.J., Sharma, A., Alpert, M.A., et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58 (2016), 393–400.
109. Lavie, C.J., Alpert, M.A., Arena, R., Mehra, M.R., Milani, R.V., Ventura, H.O., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1 (2013), 93–102.
110. Neeland, I.J., Ayers, C.R., Rohatgi, A.K., et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 21 (2013), E439–E447.
111. Park, J., Kim, N.H., Kim, S.H., et al. Visceral adiposity and skeletal muscle mass are independently and synergistically associated with left ventricular structure and function: the Korean genome and epidemiology study. Int J Cardiol 176 (2014), 951–955.
112. Zlobine, I., Gopal, K., Ussher, J.R., Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim Biophys Acta 1861 (2016), 1555–1568.
113. Towfighi, A., Zheng, L., Ovbiagele, B., Weight of the obesity epidemic: rising stroke rates among middle-aged women in the United States. Stroke 41 (2010), 1371–1375.
114. Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004), 2471–2477.
115. Duflou, J., Virmani, R., Rabin, I., Burke, A., Farb, A., Smialek, J., Sudden death as a result of heart disease in morbid obesity. Am Heart J 130 (1995), 306–313.
116. Wilson, P.W.F., D'Agostino, R.B., CHD risk in persons with diabetes mellitus or with known coronary heart disease. Circulation 106 (2002), II–509.
117. Madala, M.C., Franklin, B.A., Chen, A.Y., et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 52 (2008), 979–985.
118. See, R., Abdullah, S.M., McGuire, D.K., et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas heart study. J Am Coll Cardiol 50 (2007), 752–759.
119. Kronmal, R.A., McClelland, R.L., Detrano, R., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the multi-ethnic study of atherosclerosis (MESA). Circulation 115 (2007), 2722–2730.
120. Karason, K., Wikstrand, J., Sjostrom, L., Wendelhag, I., Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes Relat Metab Disord 23 (1999), 948–956.
121. Arkin, J.M., Alsdorf, R., Bigornia, S., et al. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardiol 101 (2008), 98–101.
122. Kortelainen, M.L., Sarkioja, T., Visceral fat and coronary pathology in male adolescents. Int J Obes Relat Metab Disord 25 (2001), 228–232.
123. Sturm, W., Sandhofer, A., Engl, J., et al. Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity (Silver Spring) 17 (2009), 1783–1788.
124. Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L., Redfield, M.M., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006), 251–259.
125. Bursi, F., Weston, S.A., Redfield, M.M., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006), 2209–2216.
126. Abebe, T.B., Gebreyohannes, E.A., Tefera, Y.G., Abegaz, T.M., Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord, 16, 2016, 232.
127. Barbosa, J.A., Rodrigues, A.B., Mota, C.C., Barbosa, M.M., Simoes e Silva AC. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods. Vasc Health Risk Manag 7 (2011), 287–295.
128. Wong, C.Y., O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110 (2004), 3081–3087.
129. Turkbey, E.B., McClelland, R.L., Kronmal, R.A., et al. The impact of obesity on the left ventricle: the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging 3 (2010), 266–274.
130. Wende, A.R., Abel, E.D., Lipotoxicity in the heart. Biochim Biophys Acta 1801 (2010), 311–319.
131. Ebong, I.A., Goff, D.C. Jr., Rodriguez, C.J., Chen, H., Bertoni, A.G., Mechanisms of heart failure in obesity. Obes Res Clin Pract 8 (2014), e540–e548.
132. Banerjee, S., Peterson, L.R., Myocardial metabolism and cardiac performance in obesity and insulin resistance. Curr Cardiol Rep 9 (2007), 143–149.
133. Ortega, F.B., Lavie, C.J., Blair, S.N., Obesity and cardiovascular disease. Circ Res 118 (2016), 1752–1770.
134. Sharma, A., Lavie, C.J., Borer, J.S., et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115 (2015), 1428–1434.
135. Shah, R., Gayat, E., Januzzi, J.L. Jr., et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63 (2014), 778–785.
136. Lavie, C.J., Ventura, H.O., The obesity paradox in heart failure: is it all about fitness, fat, or sex?. JACC Heart Fail 3 (2015), 927–930.
137. Vest, A.R., Wu, Y., Hachamovitch, R., Young, J.B., Cho, L., The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 3 (2015), 917–926.
138. Lavie, C.J., Cahalin, L.P., Chase, P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88 (2013), 251–258.
139. Oktay, A.A., Lavie, C.J., Kokkinos, P.F., Parto, P., Pandey, A., Ventura, H.O., The interaction of cardiorespiratory fitness with obesity and the obesity paradox in cardiovascular disease. Prog Cardiovasc Dis 60 (2017), 30–44.
140. Lavie, C.J., Pandey, A., Lau, D.H., Alpert, M.A., Obesity, Sanders P., Atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 70 (2017), 2022–2035.
141. Wanahita, N., Messerli, F.H., Bangalore, S., Gami, A.S., Somers, V.K., Steinberg, J.S., Atrial fibrillation and obesity–results of a meta-analysis. Am Heart J 155 (2008), 310–315.
142. Tsang, T.S., Barnes, M.E., Miyasaka, Y., et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29 (2008), 2227–2233.
143. Lim, T.K., Dwivedi, G., Hayat, S., Majumdar, S., Senior, R., Independent value of left atrial volume index for the prediction of mortality in patients with suspected heart failure referred from the community. Heart 95 (2009), 1172–1178.
144. Stritzke, J., Markus, M.R., Duderstadt, S., et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol 54 (2009), 1982–1989.
145. Sjöström, L., Lindroos, A.K., Peltonen, M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004), 2683–2693.
146. Piche, M.E., Auclair, A., Harvey, J., Marceau, S., Poirier, P., How to choose and use bariatric surgery in 2015. Can J Cardiol 31 (2015), 153–166.
147. Sjostrom, L., Peltonen, M., Jacobson, P., et al. Bariatric surgery and long-term cardiovascular events. JAMA 307 (2012), 56–65.
148. Sjostrom, L., Narbro, K., Sjostrom, C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007), 741–752.
149. Gloy, V.L., Briel, M., Bhatt, D.L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, f5934, 2013, 347.
150. Vest, A.R., Heneghan, H.M., Agarwal, S., Schauer, P.R., Young, J.B., Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 98 (2012), 1763–1777.
151. Kwok, C.S., Pradhan, A., Khan, M.A., et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol 173 (2014), 20–28.
152. Kim, J., Eisenberg, D., Azagury, D., Rogers, A., Campos, G.M., American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis 12 (2016), 453–459.